|
Market Closed -
Xetra
11:35:48 2026-08-18 EDT
|
Pre-market 01:05:02 | |||
| 63.50 EUR | +1.96% |
|
63.50 | 0.00% |
| 08-13 | Health Care Down on Cyclical Bias - Health Care Roundup | DJ |
| 08-13 | Zoetis Gets FDA Emergency-Use Approval for Screwworm in Dogs | DJ |
Company Valuation: Zoetis Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 115,457 | 68,303 | 90,615 | 73,508 | 55,448 | 30,562 | - | - |
| Change | - | -40.84% | 32.67% | -18.88% | -24.57% | -44.88% | - | - |
| Enterprise Value (EV) 1 | 118,564 | 72,626 | 95,138 | 78,091 | 62,178 | 37,683 | 36,941 | 36,271 |
| Change | - | -38.75% | 31% | -17.92% | -20.38% | -39.4% | -1.97% | -1.81% |
| P/E | 57.1x | 32.6x | 38.9x | 29.8x | 20.9x | 13.2x | 12x | 11.2x |
| PBR | 25.4x | 15.4x | 18.1x | 15.3x | 16.1x | 9.25x | 7.39x | 6.04x |
| PEG | - | 6.33x | 3x | 3.78x | 2.1x | -1.94x | 1.27x | 1.5x |
| Capitalization / Revenue | 14.8x | 8.45x | 10.6x | 7.94x | 5.86x | 3.3x | 3.2x | 3.08x |
| EV / Revenue | 15.2x | 8.99x | 11.1x | 8.44x | 6.57x | 4.07x | 3.87x | 3.66x |
| EV / EBITDA | 34.5x | 20.4x | 25.6x | 19.3x | 14.7x | 9.45x | 9.02x | 8.44x |
| EV / EBIT | 39.7x | 23.5x | 29.4x | 22.1x | 16.6x | 10.9x | 10.1x | 9.53x |
| EV / FCF | 68.3x | 54.8x | 58.7x | 34x | 27.2x | 15.9x | 13.1x | 12.4x |
| FCF Yield | 1.46% | 1.83% | 1.7% | 2.94% | 3.67% | 6.3% | 7.63% | 8.08% |
| Dividend per Share 2 | 1.075 | 1.35 | 1.557 | 1.796 | 2.03 | 2.14 | 2.3 | 2.504 |
| Rate of return | 0.44% | 0.92% | 0.79% | 1.1% | 1.61% | 2.89% | 3.11% | 3.39% |
| EPS 2 | 4.27 | 4.49 | 5.07 | 5.47 | 6.02 | 5.61 | 6.14 | 6.598 |
| Distribution rate | 25.2% | 30.1% | 30.7% | 32.8% | 33.7% | 38.2% | 37.5% | 38% |
| Net sales 1 | 7,776 | 8,080 | 8,544 | 9,256 | 9,467 | 9,263 | 9,557 | 9,908 |
| EBITDA 1 | 3,434 | 3,561 | 3,722 | 4,036 | 4,240 | 3,987 | 4,096 | 4,298 |
| EBIT 1 | 2,986 | 3,096 | 3,231 | 3,539 | 3,753 | 3,469 | 3,644 | 3,806 |
| Net income 1 | 2,037 | 2,114 | 2,344 | 2,486 | 2,673 | 2,361 | 2,488 | 2,527 |
| Net Debt 1 | 3,107 | 4,323 | 4,523 | 4,583 | 6,730 | 7,121 | 6,379 | 5,709 |
| Reference price 2 | 244.03 | 146.55 | 197.37 | 162.93 | 125.82 | 73.96 | 73.96 | 73.96 |
| Nbr of stocks (in thousands) | 473,126 | 466,072 | 459,114 | 451,165 | 440,693 | 413,224 | - | - |
| Announcement Date | 2/15/22 | 2/14/23 | 2/13/24 | 2/13/25 | 2/12/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 13.01x | 4.02x | 9.35x | 2.93% | 30.56B | |
| 171.09x | 2.89x | 14.6x | -.--% | 11.81B | |
| 14.6x | 1.12x | 4.14x | 3.36% | 3.95B | |
| 16.14x | 1.86x | 9.15x | 0.52% | 3.2B | |
| 60.56x | - | - | 0.59% | 2.18B | |
| 34.71x | 3.93x | 14.06x | -.--% | 1.94B | |
| 13.99x | 1.3x | 7.75x | 1.38% | 1.41B | |
| 19.7x | 2.43x | 11.66x | 1.59% | 1.27B | |
| 33x | - | - | 0.45% | 1.03B | |
| Average | 41.87x | 2.51x | 10.10x | 1.2% | 6.37B | |
| Weighted average by Cap. | 48.92x | 3.32x | 10.28x | 1.92% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ZTS Stock
- ZOE Stock
- Valuation Zoetis Inc.
Select your edition
All financial news and data tailored to specific country editions
